Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure

Medical Science Monitor

Volumn 15, Issue 6, 2009, Pages

  Kuch, Marek ^a,b   Janiszewski, Maciej ^a   Mamcarz, Artur ^a   Cudnoch Jȩdrzejewska, Agnieszka ^a   Dłuzniewski, Mirosław ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Brodnowski Hospital Warsaw   (Poland)

Author keywords

Adverse cardiac events; Myocardial infarction

Indexed keywords

CHOLESTEROL;

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; HEART RATE VARIABILITY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; PREDICTION; PROGNOSIS; QT INTERVAL; RISK FACTOR; SEX DIFFERENCE; ST SEGMENT ELEVATION; SUDDEN DEATH; SURVIVAL;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; DEATH, SUDDEN, CARDIAC; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; POLAND; SURVIVORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 66749117354     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Mosterd A, Hoes AW, de Bruyne MC et al: Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J, 1999; 20: 447-455
2. Hunt SA: American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005; 46: e1-82, erratum in: J Am Coll Cardiol, 2006; 47: 1503-1505
3. Wang TJ, Evans JC, Benjamin EJ et al: Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation, 2003; 108: 977-982 (Pubitemid 37048228)
4. Redfield MM, Jacobsen SJ, Burnett JC Jr et al: Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA, 2003; 289: 194-202 (Pubitemid 36068707)
5. Gheorghiade M, Bonow RO: Chronic heart failure in the United States: a manifestation of coronary disease. Circulation, 1998; 97: 282-289 (Pubitemid 28067315)
6. Cleland JG, Swedberg K, Follath F et al: The Euro Heart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patients characteristics and diagnosis. Eur Heart J, 2003; 24: 442-463
7. MacIntyre K, Capewell S, Stewart S et al: Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation, 2000; 102: 1126-1131
8. Yang P, Allen MS, Aubry MC et al: Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest, 2005; 128: 452-462
9. Krum H: The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology: Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005). Eur Heart J, 2005; 26: 2472-2474
10. La Rovere MT, Pinna GD, Maestri R et al: Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation, 2003; 107: 565-570 (Pubitemid 36176805)
11. Kearney MT, Fox KA, Lee AJ et al: Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol, 2002; 40: 1801-1808 (Pubitemid 35341959)
12. Cohn JN, Johnson GR, Shabetai R et al: Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation, 1993; 87(Suppl.6): V15-16
13. Hillege HL, Nitsch D, Pfeffer MA et al: Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation, 2006; 113: 671-678
14. Gronda E, Mangiavacchi M, Frigerio M et al: Determination of candidacy for mechanical circulatory support: importance of clinical indicates. J Heart Lung Transplant, 2000; 19: S83-88 (Pubitemid 30658220)
15. Bruch C, Rothenburger M, Gotzmann M et al: Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment. J Am Soc Echocardiogr, 2006; 19: 522-528
16. Nohria A, Tsang SW, Fang JC et al: Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol, 2003; 41: 1797-1804 (Pubitemid 36584255)
17. Anker SD, Negassa A, Coats AJ et al: Prognostic importance of weight loss in chronic heart failure and effect of treatment with angiotensin-converting- enzyme inhibitors: an observational study. Lancet, 2003; 361: 1077-1083 (Pubitemid 36369559)
18. MERIT-HF: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Interventional in Congestive Heart Failure. Lancet, 1999; 353: 2001-2007 (Pubitemid 29271744)
19. Cowburn PJ, Cleland JG, Coats AJ, Komajda M: Risk stratification in chronic heart failure. Eur Heart J, 1998; 19: 696-710 (Pubitemid 28227152)
20. Dries DL, Sweitzer NK, Drazner MH et al: Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol, 2001; 38: 421-428 (Pubitemid 32721770)
21. From AM, Leibson CL, Bursi F et al: Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med, 2006; 119: 591-599 (Pubitemid 44041273)
22. Cohn JN: Prevention of heart failure. Cardiology, 1999; 92(Suppl.1): 22-25
23. Wang TJ, Levy D, Benjamin EJ, Vasan RS: The epidemiology of "asymptomatic left ventricular systolic dysfunction: implications for screening. Ann Intern Med, 2003; 138: 907-916
24. Pocock SJ, Wang D, Pfeffer MA et al: On behalf of the CHARM investigators. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J, 2006; 27: 65-75
25. Rich MW, McSherry F, Williford WO, Yusuf S: Digitalis Investigation Group. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. J Am Coll Cardio, 2001; 38: 806-813 (Pubitemid 32835757)
26. Anand IS, Kuskowski MA, Rector TS et al: Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation, 2005; 112: 1121-1127 (Pubitemid 41216118)
27. Levy D, Kenchaiah S, Larson MG et al: Long-term trends in the incidence of and survival with heart failure. N Engl J Med, 2002; 347: 1397-1402 (Pubitemid 35239711)
28. Adams KF Jr, Dunlap SH, Sueta CA et al: Relation between sex, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol, 1996; 28: 1781-1788 (Pubitemid 26426235)
29. Grigioni F, Barberi A, Russo A et al: Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of sex as compared with sex-related characteristics. J Heart Lung Transplant, 2006; 25: 648-652 (Pubitemid 43766582)
30. Cohn JN, Johnson GR, Shabetai R et al: Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation, 1993; 87: V15-16
31. Unverferth DV, Magorien RD, Moeschberger ML et al: Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol, 1984; 54: 147-152 (Pubitemid 14085366)
32. Lee TH, Hamilton MA, Stevenson LW et al: Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol, 1993; 72: 672-676 (Pubitemid 23273556)
33. Wong M, Johnson G, Shabetai R et al: Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs cooperative studies V-HeFT I and II. VHeFT VA Cooperative Studies Group. Circulation, 1993; 87: V165-70
34. Domański M, Krause-Steinrauf H, Deedwania P et al: BEST Investigators. Influence of diabetes mellitus on outcomes of patients with advances heart failure in the BEST trial36.. J Am Coll Cardiol, 2003; 42: 914-922
35. From AM, Leibson CL, Bursi F et al: Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med, 2006; 119: 591-599 (Pubitemid 44041273)
36. Altimir S, Lupon J, Gonzalez B et al: Sex and age differences in fragility in a heart failure population. Eur J Heart Fail, 2005; 7: 798-802 (Pubitemid 41125896)
37. Futterman LG, Lemberg L: Heart failure: update on treatment and prognosis. Am J Crit Care, 2001; 10: 285-293 (Pubitemid 33605317)